Durata (DRTX) Files $86.25M IPO
Get Alerts DRTX Hot Sheet
Join SI Premium – FREE
Durata (Nasdaq: DRTX) filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The proposed maximum offering price is $86.25 million. Durata plans to list on the Nasdaq Global Market under the ticker, "DRTX."
The offering is being made through BofA Merrill Lynch, Credit Suisse, RBC Capital Markets, and Wedbush PacGrow Life Sciences.
Durata is a pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses.
The offering is being made through BofA Merrill Lynch, Credit Suisse, RBC Capital Markets, and Wedbush PacGrow Life Sciences.
Durata is a pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tungray Technologies (TRSG) Prices 1.25M Share IPO at $4/sh
- Xcel Energy (XEL) Files Mixed Shelf
- Tupperware Brands (TUP) Receives NYSE Notice Regarding Late 2023 10-K Filing
Create E-mail Alert Related Categories
IPOsRelated Entities
Credit Suisse, RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!